EX1 Intrinsic Valuation and Fundamental Analysis - Exopharm Ltd

Watchlist Manager

Watchlist

Price: 0.023 AUD Market Closed

Market Cap: AU$1.6m

	Exopharm Ltd ASX:EX1	AU
	Exelon Corp NASDAQ:EXC	US
	Alan Allman Associates SA PAR:AAA	FR
	Kasikornbank PCL SET:KBANK	TH
	Sensei Biotherapeutics Inc F:407	US
	Grupo Bimbo SAB de CV OTC:GRBMF	MX
	John Wiley & Sons Inc NYSE:WLY	US

Intrinsic Value

EX1 doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value for Exopharm Ltd.

Why combine DCF with multiples? What is Intrinsic Value?

Fundamental Analysis

Jun 2020 Dec 2020 Jun 2021 Dec 2021 Jun 2022 Dec 2022 Jun 2023 Dec 2023

Wall St
Price Targets

Dividends

Buyback Yield

What is Buyback Yield?

Debt Paydown Yield

What is Debt Paydown Yield?

Competitive Landscape

Ownership

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.